Sinopharm files updated board and committee member list for disclosure purposes

PUBT · 2d ago
Sinopharm files updated board and committee member list for disclosure purposes
  • Sinopharm updated its board and committee roster dated Aug. 18, 2026.
  • Jin Bin chairs the board. Lian Wanyong serves as president.
  • Wu Tak Lung chairs the Audit Committee. Li Peiyu chairs the Remuneration Committee.
  • Yu Weifeng chairs the Legal, Compliance and ESG Committee.
  • Jin Bin chairs the Nomination Committee. Jin Bin also chairs the Strategy and Investment Committee.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260818-12288968), on August 18, 2026, and is solely responsible for the information contained therein.